Everest Medicines Limited (HKG:1952)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
58.45
+1.65 (2.90%)
Apr 3, 2025, 4:08 PM HKT

Everest Medicines Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Revenue
706.68125.9312.790.05-
Upgrade
Revenue Growth (YoY)
461.16%884.46%23588.89%--
Upgrade
Cost of Revenue
177.7934.414.650.02-
Upgrade
Gross Profit
528.8991.528.150.03-
Upgrade
Selling, General & Admin
758.15396.57603.23440.83311.08
Upgrade
Research & Development
528.04540.05809.74613.43377.41
Upgrade
Other Operating Expenses
22.926.16-0.12-4.96-0.98
Upgrade
Operating Expenses
1,309942.781,4131,049687.51
Upgrade
Operating Income
-780.21-851.27-1,405-1,049-687.51
Upgrade
Interest Expense
-22.19-23.06-5.59-4.81-33.87
Upgrade
Interest & Investment Income
95.21107.6738.4828.882.04
Upgrade
Currency Exchange Gain (Loss)
19.51-28.07-155.1822.94-0.85
Upgrade
Other Non Operating Income (Expenses)
2.652.82-1.61-6.46-4,938
Upgrade
EBT Excluding Unusual Items
-685.03-791.91-1,529-1,009-5,658
Upgrade
Gain (Loss) on Sale of Investments
-0.010.85-21.75--
Upgrade
Gain (Loss) on Sale of Assets
--1.431,320--
Upgrade
Asset Writedown
-356.34-51.97-16.49--
Upgrade
Pretax Income
-1,041-844.46-247.28-1,009-5,658
Upgrade
Income Tax Expense
--0.01--
Upgrade
Net Income
-1,041-844.46-247.28-1,009-5,658
Upgrade
Net Income to Common
-1,041-844.46-247.28-1,009-5,658
Upgrade
Shares Outstanding (Basic)
32131329829385
Upgrade
Shares Outstanding (Diluted)
32131329829385
Upgrade
Shares Change (YoY)
2.51%5.18%1.49%243.61%1532.82%
Upgrade
EPS (Basic)
-3.24-2.70-0.83-3.44-66.29
Upgrade
EPS (Diluted)
-3.24-2.70-0.83-3.44-66.29
Upgrade
Free Cash Flow
-744.92-886.53-1,512-839.89-480.5
Upgrade
Free Cash Flow Per Share
-2.32-2.83-5.08-2.86-5.63
Upgrade
Gross Margin
74.84%72.67%63.69%57.41%-
Upgrade
Operating Margin
-110.41%-675.97%-10981.12%-1943096.30%-
Upgrade
Profit Margin
-147.36%-670.57%-1933.11%-1867998.15%-
Upgrade
Free Cash Flow Margin
-105.41%-703.97%-11817.36%-1555344.44%-
Upgrade
EBITDA
-670.04-795.72-1,391-1,043-683.03
Upgrade
EBITDA Margin
-94.82%----
Upgrade
D&A For EBITDA
110.1755.5513.816.214.48
Upgrade
EBIT
-780.21-851.27-1,405-1,049-687.51
Upgrade
EBIT Margin
-110.41%----
Upgrade
Updated Aug 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.